# Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa

> **NCT01560715** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 50 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **BIOLOGICAL:** intravitreal injection of autologous bone marrow stem cells

## Key facts

- **NCT ID:** NCT01560715
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01560715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01560715, "Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01560715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*